133 related articles for article (PubMed ID: 8726526)
1. Genetic pharmacomodulation of nucleoside analogues and gene therapy for AIDS and cancer.
Guettari N; Loubière L; Caruso M; Klatzmann D
Antibiot Chemother (1971); 1996; 48():198-204. PubMed ID: 8726526
[No Abstract] [Full Text] [Related]
2. The treatment of AIDS and cancer in the third millennium.
Gallo RC
Am J Med; 1995 Dec; 99(6A):6S-10S. PubMed ID: 8585540
[No Abstract] [Full Text] [Related]
3. Gene therapy for cancer.
Blaese RM
Sci Am; 1997 Jun; 276(6):111-5. PubMed ID: 9163943
[No Abstract] [Full Text] [Related]
4. Minireview: DEK and gene regulation, oncogenesis and AIDS.
Sitwala KV; Mor-Vaknin N; Markovitz DM
Anticancer Res; 2003; 23(3A):2155-8. PubMed ID: 12894590
[TBL] [Abstract][Full Text] [Related]
5. Successful gene therapy has researchers looking for the bystander effect.
Seachrist L
J Natl Cancer Inst; 1994 Jan; 86(2):82-3. PubMed ID: 8271303
[No Abstract] [Full Text] [Related]
6. [Gene therapy for AIDS].
Matsukura M
Nihon Ika Daigaku Zasshi; 1995 Oct; 62(5):528-9. PubMed ID: 7499472
[No Abstract] [Full Text] [Related]
7. Biochemical aspects of the selective antiherpes activity of nucleoside analogues.
De Clercq E
Biochem Pharmacol; 1984 Jul; 33(14):2159-69. PubMed ID: 6147138
[No Abstract] [Full Text] [Related]
8. Metabolic suicide genes in gene therapy.
Mullen CA
Pharmacol Ther; 1994 Aug; 63(2):199-207. PubMed ID: 7809180
[TBL] [Abstract][Full Text] [Related]
9. Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS.
He J; Zhang T; Fu X
Protein Cell; 2017 Nov; 8(11):848-852. PubMed ID: 28822100
[No Abstract] [Full Text] [Related]
10. Gene therapy for infectious diseases: the AIDS model.
Gilboa E; Smith C
Trends Genet; 1994 Apr; 10(4):139-44. PubMed ID: 7913251
[TBL] [Abstract][Full Text] [Related]
11. In situ delivery of suicide genes for cancer treatment.
Blaese RM; Ishii-Morita H; Mullen C; Ramsey J; Ram Z; Oldfield E; Culver K
Eur J Cancer; 1994; 30A(8):1190-3. PubMed ID: 7654455
[No Abstract] [Full Text] [Related]
12. Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cells.
Morin KW; Duan W; Xu L; Zhou A; Moharram S; Knaus EE; McEwan AJ; Wiebe LI
Nucl Med Biol; 2004 Jul; 31(5):623-30. PubMed ID: 15219281
[TBL] [Abstract][Full Text] [Related]
13. Modulated nucleoside kinases as tools to improve the activation of therapeutic nucleoside analogues.
Monnerjahn C; Konrad M
Chembiochem; 2003 Mar; 4(2-3):143-6. PubMed ID: 12616626
[TBL] [Abstract][Full Text] [Related]
14. Delivering therapeutic genes--matching approach and application.
Mitani K; Caskey CT
Trends Biotechnol; 1993 May; 11(5):162-6. PubMed ID: 7763805
[No Abstract] [Full Text] [Related]
15. Antisense therapy.
Narayanan R; Akhtar S
Curr Opin Oncol; 1996 Nov; 8(6):509-15. PubMed ID: 8971471
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy in human cancer: report of human clinical trials.
Wasil T; Buchbinder A
Cancer Invest; 2000; 18(8):740-6. PubMed ID: 11107444
[No Abstract] [Full Text] [Related]
17. Strategies for gene therapy.
Blaese RM; Mullen CA; Ramsey WJ
Pathol Biol (Paris); 1993 Oct; 41(8):672-6. PubMed ID: 8290310
[TBL] [Abstract][Full Text] [Related]
18. The many lives of CTIP2: from AIDS to cancer and cardiac hypertrophy.
Le Douce V; Cherrier T; Riclet R; Rohr O; Schwartz C
J Cell Physiol; 2014 May; 229(5):533-7. PubMed ID: 24122342
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 genome engineering in hematopoietic cells.
Sürün D; von Melchner H; Schnütgen F
Drug Discov Today Technol; 2018 Aug; 28():33-39. PubMed ID: 30205879
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex amplicon vectors.
Link CJ; Vahanian NN; Wang S
Methods Mol Med; 2003; 76():61-87. PubMed ID: 12526159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
